Home
Cannapedia Encyclopedia of cannabis strains

Primary tabs

Seedbank

Holy Grail

Average rating: 4.2 (15× ratings)

Drum Roll Please…We now introduce THE HOLY GRAIL KUSH!! All of us growers have been searching for the one plant, if you had to pick only one, to have with you on a deserted island... Well the search can be temporarily suspended. DNA presents the cannabis community with the 2 time Cannabis Cup Champion, Kosher Kush, crossed with the Multi-Champion strain, The OG #18, bringing you... The Holy Grail Kush! This cross produces large resinous buds that reak of OG #18/Kosher goodness!! New, or fairly new, carbon filters are highly recommended as the smell can be over powering! The Holy Grail is great for the beginner as well as the Master grower. The experienced growers can take her to the limit, pushing the nutrient uptake to the very edge and being rewarded with insanely aromatic plants with the strength and yield not to be matched! The Holy Grail will demand the highest price of all the OG Kush hybrids. Several High Times staff were heard talking of how superior the Holy Grail Kush was in looks, smell and taste. Far out performing ALL other entries in 2011 HTCC to take First place with a first ever perfect score!! Now the world can try The Holy Grail Kush! 1st Hybrid HT Cannabis Cup 2011 2nd Indoor Hydro Spannabis 2012.

Fundamental parameters

Information about the origin and the life cycles of plants

Type
mostly indica
Indoor flowering time
9 weeks
Genetics
Kosher Kush x The OG #18
Breeder
DNA Genetic
Country
Netherlands

Indication

What difficulties can help this variety

Effects

As this variety will be affect on you

Diskuze

Add comment
Major (not verified)
9 years 7 months
Insufficient funds essay the help movie The committee notes how Google generated $18bn (£11.8bn) of revenue from Britain between 2006 and 2011 but paid just $16m of UK corporation tax, while Starbucks “took advantage of the rules to reduce its corporation tax liability in the UK to the minimum”. It then only volunteered to pay £20m “to head off a consumer boycott”.
5158
Isaiah (not verified)
9 years 7 months
I'm retired argument essay outlines Rigel also said it met with the U.S. Food and Drug Administration to discuss fostamatimib as a treatment for a blood disorder, and would start two late-stage studies of the drug in the first half of 2014.
5158

In the database, there are no reviews. Be the first one is reviewing this product!